cohort·critical care, clinical trial, surgery, internal medicine, research methods·PMC10099025
A bedside swallowing screen for the identification of post-extubation dysphagia on the intensive care unit – validation of the Gugging Swallowing Screen (GUSS)—ICU
BMC Anesthesiology · 6 authors, 6 centres
AI SUMMARY
FIDELITY 100%
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This prospective study validated a modified bedside swallowing screen (GUSS-ICU) for post-extubation patients in the ICU. The GUSS-ICU showed high sensitivity and specificity when compared to the gold standard flexible endoscopic evaluation of swallowing (FEES).
Full summary
917 CHARS
This prospective cohort study validated the GUSS-ICU, a modified multi-consistency bedside swallowing screen, in 45 ICU patients extubated for at least 24 hours. The GUSS-ICU was performed by two independent speech-language therapists and compared to the gold standard flexible endoscopic evaluation of swallowing (FEES) performed by an otorhinolaryngologist. FEES diagnosed dysphagia in 36 of 45 participants (80%). The GUSS-ICU demonstrated high diagnostic accuracy, with an area under the curve of 0.923 for both rater pairs, sensitivity of 91.7% and 94.4%, and specificity of 88.9% and 66.7%. Interrater reliability was good (Cohen's Kappa = 0.84). The study concludes the GUSS-ICU is a valid and reliable tool for early dysphagia identification in the ICU. Limitations include its monocentric design, a relatively small sample size, and the heterogeneity of the ICU population, which may affect generalizability.